Green light for diagnostic autism app raises questions, concerns
The company aims to release the app and the rest of the Canvas Dx system in the United States by the end of 2021, says Sharief Taraman, Cognoa’s chief medical officer. In 2018, Cognoa caused confusion among some autism researchers by announcing that the app had been designated an FDA Class II diagnostic medical device, […]